Brain Metastases in Non-Small-Cell Lung Cancer

被引：27
|
作者：
Dawe, David E. [1 ]
Greenspoon, Jeffrey N. [2 ]
Ellis, Peter M. [2 ]
机构：
[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 0V9, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
来源：
CLINICAL LUNG CANCER | 2014年 / 15卷 / 04期
关键词：
Chemotherapy; Radiotherapy; Review; Stereotactic radiosurgery; Targeted agents; PROPHYLACTIC CRANIAL IRRADIATION; RANDOMIZED PHASE-III; GRADED PROGNOSTIC ASSESSMENT; NERVOUS-SYSTEM PROGRESSION; PARTITIONING ANALYSIS RPA; GAMMA-KNIFE SURGERY; RADIATION-THERAPY; STEREOTACTIC RADIOSURGERY; MOTEXAFIN GADOLINIUM; SINGLE METASTASES;
D O I：
10.1016/j.cllc.2014.04.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Up to 50% of patients with advanced non-small-cell lung cancer will develop brain metastases at some point during their illness. These metastases cause a substantial burden in morbidity and mortality, which has motivated research and technological innovation over the past 2 decades. Surgery, radiotherapy, and systemic therapies have each played a role in management, with the greatest changes associated with the popularization of stereotactic radiosurgery. In this review, the evidence behind each modality used in the management of brain metastases for non small-cell lung cancer patients is examined, and recommendations regarding the current standards of care and areas of future research focus are provided. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码：249 / 257
页数：9
相关论文
共 50 条
  • [21] Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer
    Bulbul, Ajaz
    Forde, Patrick M.
    Murtuza, Ayesha
    Woodward, Brian
    Yang, Hannah
    Bastian, Ingmar
    Ferguson, Parissa K.
    Lopez-Diaz, Fernando
    Ettinger, David S.
    Husain, Hatim
    ONCOLOGY-NEW YORK, 2018, 32 (04): : 156 - 163
  • [22] Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases
    Ali, A.
    Goffin, J. R.
    Arnold, A.
    Ellis, P. M.
    CURRENT ONCOLOGY, 2013, 20 (04) : E300 - E306
  • [23] Brain metastases in patients with EGFR-mutant non-small-cell lung cancer
    Rosell, Rafael
    Karachaliou, Niki
    LANCET RESPIRATORY MEDICINE, 2017, 5 (09): : 669 - 671
  • [24] Factors predicting silent brain metastases in patients with non-small-cell lung cancer
    Na, I.
    Lee, T.
    Choe, D.
    Kang, H.
    Koh, J.
    Park, J.
    Baek, H.
    Kim, C.
    Ryoo, B.
    Lee, J.
    Yang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Targeting brain metastases in ALK-rearranged non-small-cell lung cancer
    Zhang, Isabella
    Zaorsky, Nicholas G.
    Palmer, Joshua D.
    Mehra, Ranee
    Lu, Bo
    LANCET ONCOLOGY, 2015, 16 (13): : E510 - E521
  • [26] Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
    Huang, Zhangheng
    Hu, Chuan
    Tong, Yuexin
    Fan, Zhiyi
    Zhao, Chengliang
    MEDICINE, 2020, 99 (31)
  • [27] Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases
    Werner, Raphael S.
    Rechsteiner, Markus
    Moch, Holger
    Curioni-Fontecedro, Alessandra
    Weller, Michael
    Weiss, Tobias
    Regli, Luca
    Le Rhun, Emilie
    Mairinger, Fabian
    Opitz, Isabelle
    Soltermann, Alex
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (06)
  • [28] Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy
    Zabel, A
    Debus, A
    LUNG CANCER, 2004, 45 : S247 - S252
  • [29] Therapeutic strategy for non-small-cell lung cancer patients with brain metastases (Review)
    Kim, Young Hak
    Nagai, Hiroki
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Mishima, Michiaki
    BIOMEDICAL REPORTS, 2013, 1 (05) : 691 - 696
  • [30] Management of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer
    Rusthoven, Chad G.
    Doebele, Robert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2814 - +
12345